The Remaining Smallpox Virus Stocks Are Too Valuable To Be Destroyed

Smallpox, or variola, virus has killed more human beings than any other infectious agent. Fortunately, smallpox virus has only one host-humans -- which made it possible to eradicate it. In 1967, the World Health Organization (WHO) initiated a brilliant campaign that, within 10 years, eradicated smallpox virus from human populations, the last case occurring in Somalia in 1977. Illustration: John Overmeyer Soon after, the question arose as to what to do with the smallpox isolates stored in lab

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Smallpox, or variola, virus has killed more human beings than any other infectious agent. Fortunately, smallpox virus has only one host-humans -- which made it possible to eradicate it. In 1967, the World Health Organization (WHO) initiated a brilliant campaign that, within 10 years, eradicated smallpox virus from human populations, the last case occurring in Somalia in 1977.

Illustration: John Overmeyer Soon after, the question arose as to what to do with the smallpox isolates stored in laboratories throughout the world. In 1981, WHO recommended that all isolates be destroyed, with the exception of stocks held at the Centers for Disease Control in Atlanta and at the Institute for Viral Preparations in Moscow. WHO also recommended that the genomes of several smallpox virus isolates be cloned into plasmids and sequenced. With that achieved, some scientists and government officials claimed that the smallpox virus stocks in Atlanta and Moscow are superfluous, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Wolfgang Joklik

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio